CINCINNATI (WKRC) — As summer draws to a close, AstraZeneca has introduced a new way to fight the flu with the launch of FluMist Home, the first-ever home-administered flu vaccine. This innovative ...
Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...
Pharma company AstraZeneca has publicly released preclinical data from more than 50 of its medicines in order to find new drug combinations for cancer treatments. The data AstraZeneca released will be ...
Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL), a global clinical-stage biopharmaceutical ...
(Alliance News) - AstraZeneca on Tuesday hailed encouraging test results for its hypoparathyroidism drug eneboparatide. Shares in the Cambridge, England-based pharmaceutical firm rose 0.2% to ...
(Alliance News) - AstraZeneca PLC on Sunday said Imfinzi has been approved in the EU as the first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers. The ...
AstraZeneca has succumbed to pressure from US president Donald Trump to reduce the cost of its medications for American patients. The Cambridge-headquartered pharmaceutical giant announced it will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results